XENOPORT INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | $7.1M | $3.4M | $8.0M | $21.6M | $43.5M | $2.9M |
| Operating income | −$79.2M | −$49.1M | −$85.6M | −$31.1M | −$33.6M | −$83.3M |
| Net income | −$20.4M | −$20.5M | −$85.9M | −$30.8M | −$33.4M | −$82.5M |
| Total assets | $164.0M | $123.1M | $78.5M | $159.0M | $104.0M | $121.2M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $20.3M | $91.1M | $53.7M | $130.2M | $75.1M | $94.0M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 62.8M | 60.0M | 47.2M | 35.6M | 35.3M | 35.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- −1121.0%
- Net margin
- −288.8%
- Return on equity
- −100.5%
- Return on assets
- −12.4%
- Return on capital (ROCE)
- −54.7%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.32
- Revenue growth (YoY)
- 109.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Accruals / assets
- 32.9%high accruals
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 4 warning● 1 good- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- High accruals — earnings-quality risk
- Revenue is growing year-over-year
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventJul 5, 2016
- Entered a material agreement · Other material eventMay 23, 2016
- Shareholder vote · Other material eventMay 19, 2016
- Results of operationsMay 5, 2016
- Entered a material agreement · New financial obligationApr 11, 2016
- Director / officer changeApr 1, 2016
- Entered a material agreementMar 28, 2016
- Results of operationsFeb 25, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.